MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 86 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,019,042 | -53.3% | 190,476 | -70.6% | 0.04% | -38.6% |
| Q3 2021 | $12,894,000 | +15.2% | 647,313 | 0.0% | 0.06% | +16.3% |
| Q2 2021 | $11,192,000 | -12.8% | 647,313 | 0.0% | 0.05% | -12.5% |
| Q1 2021 | $12,830,000 | +13.5% | 647,313 | 0.0% | 0.06% | +30.2% |
| Q4 2020 | $11,302,000 | +6.1% | 647,313 | +17.1% | 0.04% | 0.0% |
| Q3 2020 | $10,656,000 | -6.1% | 553,009 | -5.2% | 0.04% | -14.0% |
| Q2 2020 | $11,352,000 | +39.0% | 583,333 | 0.0% | 0.05% | 0.0% |
| Q1 2020 | $8,167,000 | -0.1% | 583,333 | +75.0% | 0.05% | +16.3% |
| Q4 2019 | $8,173,000 | +143.8% | 333,333 | 0.0% | 0.04% | +87.0% |
| Q3 2019 | $3,353,000 | – | 333,333 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |